Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Background Implantable cardioverter-defibrillators (ICDs) are implanted with the intention to
prolong life in selected patients with inherited arrhythmia syndromes, but ICD implantation is …

Las guías de práctica clínica (GPC) tienen como objetivo reunir y evaluar toda la evidencia
relevante disponible durante el proceso de elaboración sobre un tema particular para …

Aims Sudden cardiac death (SCD) annual incidence is 0.6–1% in post-myocardial infarction
(MI) patients with left ventricular ejection fraction (LVEF)≥ 40%. No recommendations for …

It is known that myocardial ischaemia and infarction leads to severe metabolic and
electrophysiological changes that induce silent or symptomatic life-threatening arrhythmias …

The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …

Abstract Background: Patients with Brugada syndrome and aborted sudden cardiac death or
syncope have higher risks for ventricular arrhythmias (VAs) and should undergo implantable …

Ventricular electrical storm (VES) is a clinical scenario characterized by the clustering of
multiple episodes of sustained ventricular arrhythmias (VA) over a short duration. Patients …

Abstract Stowarzyszenia ESC: Acute Cardiovascular Care Association (ACCA), European
Association for Cardiovascular Prevention and Rehabilitation (EACPR), European …

Background The benefits of implantable cardioverter-defibrillators (ICDs) have been well
demonstrated in many clinical trials, and ICD shocks for ventricular tachyarrhythmias save …